Abiopharma

News list

Director Kelsey Todd P. 🔴 sold 1.5K shares of PLEXUS CORP (PLXS) at $252.23 Transaction Date: Aug 19, 2026 | Filing ID: 000020

Full text

News bot Aug. 20, 2026, 9:15 p.m.
🔍 Kelsey Todd P. (Director)

Company: PLEXUS CORP (PLXS)

Report Date: 2026-08-19
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 1,500
Detailed Transactions and Holdings:
- Sold 319 shares of Common Stock, $.01 par value at $248.7887 per share (Direct)
  Date: 2026-08-19 | Code: S | equity_swap_involved: 0 | shares_owned_after: 67,069.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 681 shares of Common Stock, $.01 par value at $251.085 per share (Direct)
  Date: 2026-08-19 | Code: S | equity_swap_involved: 0 | shares_owned_after: 66,388.00 | transaction_form_type: 4 | Footnotes: F1, F2
- Sold 500 shares of Common Stock, $.01 par value at $252.23 per share (Direct)
  Date: 2026-08-19 | Code: S | equity_swap_involved: 0 | shares_owned_after: 65,888.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Shares were sold pursuant to a Rule 10b5-1 plan adopted on November 20, 2025.
- F2: This transaction was executed in multiple trades at prices ranging from $251.00 to $251.18 per share. The reported price reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.